We summarized and illustrated in Fig. 5 how amplified/overexpressed MYCN is able to invade either enhancers or SEs in ADRN CRC, leading to enhancer/SE-driven transcription activation of genes belonging to the ADRN CRC [5]. This evidence concerns the gene MYCN and colorectal carcinoma.